Patents by Inventor Jonathan Symmons

Jonathan Symmons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220289832
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 15, 2022
    Inventors: MARIANGELA SPITALI, JONATHAN SYMMONS, RICHARD WHITCOMBE, MARK ROBERT PEARCE-HIGGINS
  • Patent number: 11339214
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: May 24, 2022
    Assignee: UCB PHARMA, S.A.
    Inventors: Mariangela Spitali, Jonathan Symmons, Richard Whitcombe, Mark Robert Pearce-Higgins
  • Patent number: 11014962
    Abstract: The present invention provides a method for manufacturing antibodies or a fragment thereof with reduced levels of antibody reduction related impurities.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: May 25, 2021
    Assignee: UCB BIOPHARMA SRL
    Inventors: Richard Jones, Jonathan Symmons, Saskia Hocking
  • Publication number: 20190153028
    Abstract: The present invention provides a method for manufacturing antibodies or a fragment thereof with reduced levels of antibody reduction related impurities.
    Type: Application
    Filed: March 31, 2017
    Publication date: May 23, 2019
    Inventors: RICHARD JONES, JONATHAN SYMMONS, SASKIA HOCKING
  • Publication number: 20190135909
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Application
    Filed: January 16, 2019
    Publication date: May 9, 2019
    Inventors: Mariangela Spitali, Jonathan Symmons, Richard Whitcombe, Mark Robert Pearce-Higgins
  • Patent number: 10189897
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: January 29, 2019
    Assignee: UCB PHARMA, S.A.
    Inventors: Mariangela Spitali, Jonathan Symmons, Richard Whitcombe, Mark Robert Pearce-Higgins
  • Publication number: 20160108119
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 21, 2016
    Inventors: Mariangela Spitali, Jonathan Symmons, Richard Whitcombe, Mark Robert Pearce-Higgins
  • Patent number: 9309280
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: April 12, 2016
    Assignee: UCB PHARMA, S.A.
    Inventors: Mariangela Spitali, Jonathan Symmons, Richard Whitcombe, Mark Robert Pearce-Higgins
  • Publication number: 20130184439
    Abstract: The present invention relates to a process for the purification of an antibody fragment from a periplasmic cell extract comprising a first cation exchange chromatography step and a second anion exchange chromatography step.
    Type: Application
    Filed: July 26, 2011
    Publication date: July 18, 2013
    Applicant: UCB PHARMA, S.A.
    Inventors: Mariangela Spitali, Jonathan Symmons, Richard Whitcombe, Mark Robert Pearce-Higgins